<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04163393</url>
  </required_header>
  <id_info>
    <org_study_id>ROB-01</org_study_id>
    <nct_id>NCT04163393</nct_id>
  </id_info>
  <brief_title>R-One Efficiency For PCI Evolution With Robotic Assistance</brief_title>
  <acronym>R-EVOLUTION</acronym>
  <official_title>R-One Efficiency For PCI Evolution With Robotic Assistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robocath</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Robocath</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a Prospective, Multi-center, Single-arm clinical study, in patients with
      Coronary Artery Disease, including patients with silent ischemia (excluding STEMI), who
      qualify for elective Percutaneous Coronary Intervention (PCI), aimed to assess the Safety and
      Efficacy of the R-One device in elective PCI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 17, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 17, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety Endpoint: Number of patients with absence of Intra-procedural complications (Dissection, Thrombus, Air embolus, traumatic aorta)</measure>
    <time_frame>Peri-procedure</time_frame>
    <description>Absence of Intra-procedural complications (Dissection &gt;/= NHLBI type D, perforation, decrease of TIMI flow (&lt;/= 2), acute occlusion, visible thrombus formation, significant air embolus, traumatic aortic or Left Main dissection by guiding catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy Endpoint: Number of Patients with Procedure technical success</measure>
    <time_frame>During Procedure</time_frame>
    <description>Procedure technical success defined as the successful advancement and retraction of all PCI devices (guidewires, balloon catheters and stents) and the successful treatment of all the target lesions using the R-One system and without conversion to manual operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with Absence of each type of Intra-procedural complication (Dissection, Thrombus, Air embolus, traumatic aorta)</measure>
    <time_frame>During Procedure</time_frame>
    <description>Component of the Primary Safety Endpoint: Absence of Intra-procedural complications (Dissection &gt;/= NHLBI type D, perforation, decrease of TIMI flow (&lt;/= 2), acute occlusion, visible thrombus formation, significant air embolus, traumatic aortic or Left Main dissection by guiding catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure duration</measure>
    <time_frame>During Procedure</time_frame>
    <description>Time between arterial sheath introduction and sheath removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Robot duration</measure>
    <time_frame>During Procedure</time_frame>
    <description>From the time when the robot begins to manipulate the guidewire to the time when the last guidewire is removed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation exposure using dosimeters (Patient Radiation, Robot Dose, Procedure Dose)</measure>
    <time_frame>During Procedure</time_frame>
    <description>Patient and Operator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Volume in mL</measure>
    <time_frame>During Procedure</time_frame>
    <description>Measure of the volume of injected contrast media</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Bleeding or Vascular Complications</measure>
    <time_frame>Up to 1 month</time_frame>
    <description>BARC definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Device Oriented Composite Criteria (Cardiovascular Death, Myocardial Infarction (peri-procedural and spontaneous), non clearly attributed to a non target or clinically driven target lesion revascularization)</measure>
    <time_frame>Post-Procedure, 1 month</time_frame>
    <description>ARC 2 definition: Cardiovascular Death, Myocardial Infarction (peri-procedural and spontaneous), non clearly attributed to a non target or clinically driven target lesion revascularization</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>R-One</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated with robotic assistance</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous Coronary Intervention</intervention_name>
    <description>PCI with robotic assistance</description>
    <arm_group_label>R-One</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous Coronary Intervention using R-One assistance</intervention_name>
    <description>PCI with robotic assistance</description>
    <arm_group_label>R-One</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years;

          -  Candidate for PCI;

          -  Presence of a de novo coronary artery stenosis of ≥ 50% and &lt;100% in a native coronary
             artery indicated and suitable for stent implantation;

          -  The vessel has a reference vessel diameter ranging from 2.5 mm to 4.0 mm;

          -  The target lesion length allows for treatment with a single stent up to 38 mm in
             length;

          -  Up to 2 target vessels each with a single target lesion requiring a single stent per
             lesion and treatable within a single procedure may be included (no further staged
             procedure allowed);

          -  The patient provides written informed consent as approved by the applicable Ethics
             Committee and is willing to comply with all study requirements including 30 days
             follow-up.

        Exclusion Criteria:

          -  Target lesion has TIMI flow &lt; 3;

          -  Treatment of in-stent restenosis, or prior stent in the target vessel proximal to the
             target lesion;

          -  More than one target lesion per vessel requiring treatment at the time of procedure;

          -  Target lesion is a bifurcation requiring balloon or stent implantation of the side
             branch, with a side-branch RVD of ≥1.5 mm with a DS ≥50% at or within 5 mm its origin,
             or RVD ≥2.0 mm regardless of the presence of side branch disease;

          -  Target lesion is located in left main coronary artery, or any left main stenosis &gt;
             30%;

          -  Target lesion is within 5 mm of the ostial LAD, ostial LCX or ostial RCA;

          -  Severe vessel tortuosity;

          -  Severe vessel calcification;

          -  STEMI, cardiopulmonary resuscitation or cardiogenic shock within 48 hours of the
             procedure;

          -  Presence of visible thrombus;

          -  Need for any procedure other than balloon angioplasty or stenting (e.g. atherectomy,
             laser, are excluded);

          -  Patients under judicial protection, tutorship or curatorship (for France only);

          -  Any patient participating in another clinical study evaluating a drug or a medical
             device (except registries for which the primary endpoint has not been evaluated;

          -  Pregnant and breast-feeding women or intention to become pregnant prior to completion
             of all follow-up procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean Fajadet, Dr</last_name>
    <phone>+33 5 62 21 31 86</phone>
    <email>jfajadet@clinique-pasteur.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric Durand, Dr</last_name>
    <phone>+33 2 32 88 82 43</phone>
    <email>eric.durand@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Het Ziekenhuisnetwerk Antwerpen vzw</name>
      <address>
        <city>Antwerpen</city>
        <zip>2000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan Verheye, Prof. Dr.</last_name>
      <email>stefan.verheye@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Caen Normandie</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rémi Sabatier, Dr</last_name>
      <email>sabatier-r@chu-caen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Durand, Dr</last_name>
      <phone>+33 2 32 88 82 43</phone>
      <email>eric.durand@chu-rouen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>INCCI</name>
      <address>
        <city>Luxembourg</city>
        <zip>L-1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bruno Pereira, Dr</last_name>
      <email>pereira.bruno@incci.lu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastad Ziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <zip>3079</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Smits, Dr</last_name>
      <email>smitsp@maastadziekenhuis.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 15, 2019</study_first_submitted>
  <study_first_submitted_qc>November 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2019</study_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

